Syndax Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	134.93	154.08	295.39	74.36	221.97
Short-Term Investments	278.76	428.83	282.19	410.04	224.87
Cash & Short-Term Investments	413.69	582.91	577.58	484.4	446.83
Cash Growth	-29.03%	0.92%	19.24%	8.41%	52.47%
Accounts Receivable	38	7.6	-	-	-
Other Receivables	30.15	3.64	-	3.47	-
Total Trade Receivables	68.15	11.24	-	3.47	-
Inventory	32.75	0.37	-	-	-
Other Current Assets	13.5	8.54	3.29	1.92	1.57
Total Current Assets	528.08	603.06	580.88	489.79	448.4
Net Property, Plant & Equipment	1.52	2.02	1.5	1.06	1.26
Long-Term Investments	-	119.52	29.83	5.47	-
Other Long-Term Assets	0.1	0.22	0.68	0.92	-
Total Assets	529.71	724.82	612.88	497.24	449.66
Accounts Payable	16.58	11.63	9.96	4.35	5.67
Accrued Expenses	103.06	60.1	39.86	24.28	14.47
Current Portion of Leases	0.47	0.48	1.05	0.44	0.36
Other Current Liabilities	-	31.35	7.23	-	0.19
Total Current Liabilities	120.12	103.55	58.1	29.07	20.68
Long-Term Debt	-	-	-	-	19.9
Long-Term Leases	1.05	1.58	0.59	0.72	0.71
Other Long-Term Liabilities	343.91	331.57	-	-	-
Total Long-Term Liabilities	344.96	333.14	0.59	0.72	20.61
Total Liabilities	465.08	436.69	58.68	29.79	41.29
Common Stock	0.01	0.01	0.01	0.01	0.01
Additional Paid-in Capital	1,571	1,509	1,456	1,161	952.02
Accumulated Other Comprehensive Income	0.45	0.16	0.22	-0.81	0.05
Retained Earnings	-1,507	-1,221	-902.4	-693.04	-543.7
Shareholders' Equity	64.63	288.12	554.2	467.45	408.37
Total Liabilities & Equity	529.71	724.82	612.88	497.24	449.66
Total Debt	1.52	2.06	1.64	1.16	20.97
Net Cash (Debt)	412.16	580.86	575.95	483.24	425.86
Net Cash Growth	-29.04%	0.85%	19.19%	13.47%	56.26%
Net Cash Per Share	4.76	6.78	8.19	7.95	7.94
Book Value	64.63	288.12	554.2	467.45	408.37
Book Value Per Share	0.75	3.37	7.88	7.69	7.62
Tangible Book Value	64.63	288.12	554.2	467.45	408.37
Tangible Book Value Per Share	0.75	3.37	7.88	7.69	7.62

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q